Pulmotil AC 250 mg/ml Concentrate for Oral Solution for Use in Drinking Water or Milk Replacer

Valsts: Lielbritānija

Valoda: angļu

Klimata pārmaiņas: VMD (Veterinary Medicines Directorate)

Nopērc to tagad

Lejuplādēt Produkta apraksts (SPC)
06-02-2023

Aktīvā sastāvdaļa:

Tilmicosin

Pieejams no:

Elanco Europe Ltd

ATĶ kods:

QJ01FA91

SNN (starptautisko nepatentēto nosaukumu):

Tilmicosin

Zāļu forma:

Concentrate for oral solution

Receptes veids:

POM-V - Prescription Only Medicine – Veterinarian

Ārstniecības grupa:

Cattle, Chickens, Pigs, Turkeys

Ārstniecības joma:

Antimicrobial

Autorizācija statuss:

Authorized

Autorizācija datums:

2000-04-04

Produkta apraksts

                                Revised: September 2020
AN: 00822/2020
Page 1 of 7
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Pulmotil AC 250 mg/ml Concentrate for Oral Solution for Use in
Drinking Water or
Milk Replacer
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
ACTIVE SUBSTANCE:
Tilmicosin (as phosphate)
250 mg/ml
EXCIPIENTS:
Propyl gallate
0.2 mg/ml
Disodium edetate
2.0 mg/ml
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Concentrate for Oral Solution for use in drinking water or milk
replacer.
Clear yellow to amber coloured solution.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Chickens (except hens producing eggs for human consumption),
Turkeys
Pigs
Calves (non ruminant)
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Pigs: For the treatment and metaphylaxis of respiratory disease in pig
herds,
associated with _Mycoplasma hyopneumoniae, Pasteurella multocida, _
_Actinobacillus pleuropneumoniae _and other organisms susceptible to
tilmicosin.
Chickens: For the treatment and metaphylaxis of respiratory disease in
chicken
flocks, associated with _Mycoplasma gallisepticum _and _M. synoviae. _
Turkeys: For the treatment and metaphylaxis of respiratory disease in
turkey
flocks, associated with _Mycoplasma gallisepticum _and _M. synoviae. _
Calves: For the treatment and metaphylaxis of bovine respiratory
disease,
associated with _Mannheimia haemolytica, Pasteurella multocida,
Mycoplasma _
_bovis, M. dispar _and other organisms susceptible to tilmicosin.
The presence of the disease in the group/flock must be established
before the
product is used.
Revised: September 2020
AN: 00822/2020
Page 2 of 7
4.3
CONTRAINDICATIONS
Do not allow horses and other equines access to drinking water
containing
tilmicosin.
Do not use in case of hypersensitivity to tilmicosin or to any of the
excipients.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
Important: Must be diluted before administration to animals.
Pigs, chickens and turkeys: Water consumption should be monitored in
order to
guarantee adequat
                                
                                Izlasiet visu dokumentu
                                
                            

Meklēt brīdinājumus, kas saistīti ar šo produktu